-
Ixekizumab, sold
under the
brand name Taltz, is an
injectable medication for the
treatment of
autoimmune diseases. Chemically, it is a form of a humanized...
- to
inhibit TNF-α signaling.
Additional monoclonal antibodies, such as
ixekizumab, have been
developed against pro-inflammatory
cytokines and
inhibit the...
-
Briakinumab L04AC10
Secukinumab L04AC11
Siltuximab L04AC12
Brodalumab L04AC13
Ixekizumab L04AC14
Sarilumab L04AC15
Sirukumab L04AC16
Guselkumab L04AC17 Tildrakizumab...
- IL-17, an
important part of the
inflammatory system:
secukinumab and
ixekizumab. They are
often considered in
cases where TNFi
drugs are not effective...
- (+hyaluronidase)
Etrasimod Filgotinib Fingolimod Guselkumab Iptacopan Itacitinib Ixekizumab Netakimab Olokizumab Ozanimod Peficitinib Pegcetacoplan Pirfenidone Ponesimod...
-
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin...
- conditions.
Guselkumab is
another monoclonal antibody against IL-23.
Ixekizumab, an IL-17A antagonist, has been
reported to have
faster onset of action...
-
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin...
-
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin...
-
ulcerative colitis, Crohn's
disease monoclonal antibody α4β7
integrin blocker ixekizumab Taltz plaque psoriasis,
psoriatic arthritis,
ankylosing spondylitis, non-radiographic...
